

Keratoprotective drug. Tears - artificial tears, improves the moistening of the cornea, increases the stability of the tear film on the surface of the cornea.
Slezin contains a water-soluble polymer system, which, in combination with the natural tear fluid of the eye, improves the moisture of the cornea, ensuring the hydrophilicity of the cornea's surface through the usual adsorption processes at the interface of the tear film and the cornea surface. The drug is physiologically mixed with a film of tear fluid, increasing its stability on the surface of the cornea. Reduces irritation symptoms associated with dry eye syndrome and protects the cornea from drying out. After a single instillation, the effect of the drug is maintained for 90 minutes.
Dry eye syndrome.
1 ml contains:
Main active ingredients:
Auxiliary components:
glycerol, boric acid, sodium tetraborate decahydrate, potassium chloride, sodium chloride, disodium edetate dihydrate, benzalkonium chloride, sodium hydroxide or hydrochloric acid, water.
Hypromellose, Dextran is marketed under different brands and generic names, and comes in different dosage forms:
Brand name | Manufacturer | Country | Dosage form |
---|---|---|---|
Slezin | K.O.Romparm Company S.R.L | Romania | eye drops |
Defislez | Synthesis AKOMP | Russia | eye drops |
Natural tear | Alcon | USA | solution |
No customer reviews for the moment.
Locally.
Instill 1-2 drops into the conjunctival sac of each affected eye as needed several times a day or as prescribed by a physician. The duration of treatment depends on the severity of the disease and is prescribed by a doctor. If there is no effect, stop the instillation of the drug.
Infrequently (0.1-1%): blurred vision, a sense of discomfort of the eye (burning, pricking).
Rarely (0.01-0.1%): eye redness, tearing, eye strain.
maybe development of allergic reactions.
Slezin is not compatible with eye drops containing metal salts (including zinc sulfate).
Use of the drug during pregnancy and lactation (breastfeeding) is possible only if the intended benefits to the mother outweigh the potential risk to the fetus or child. Adequate and strictly controlled clinical studies on the safety and efficacy of the drug during pregnancy and lactation (breastfeeding) have not been conducted.
When wearing contact lenses before instillation of the drug should be removed and re-installed no earlier than 15 minutes after applying the drug.
The drug Slezin should not be used for injection.
If there is no improvement after 2-3 days of use of the drug, it is recommended to interrupt the treatment.
Influence on ability to drive motor transport and control mechanisms
Due to the possible blurring of vision, during the period of treatment, care must be taken when driving vehicles and engaging in potentially hazardous activities that require high concentration of attention and quickness of psychomotor reactions.
Currently, no cases of an overdose of Slezina were reported.
If an excessive amount of ophthalmic solution gets into the eyes, wash the eyes with warm water.